Omar Asdrúbal Vilca Mejia

Omar Asdrúbal Vilca Mejia

Auto-generated profile, based on publicly available information

Omar Asdrúbal Vilca Mejia

Universidade de São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OMOmar Asdrúbal Vilca Mejia
Omar Asdrúbal Vilca Mejia
GBGabrielle Barbosa Borgomoni
Gabrielle Barbosa Borgomoni
NLNilza Lasta
Nilza Lasta
MOMariana Yumi Okada
Mariana Yumi Okada
MGMariana Silva Biason Gomes
Mariana Silva Biason Gomes
VFValter Furlan
Valter Furlan
The Enhanced Recovery After Surgery (ERAS) protocol affected traditional cardiac surgery processes and COVID-19 is expected to accelerate its scalability. The aim of this study was to assess the impact of an ERAS-based protocol on the length of hospital stay after cardiac surgery. From January 2019 to June 2020, 664 patients underwent consecutive cardiac surgery at a Latin American center. Here, 46 patients were prepared for a rapid recovery through a multidisciplinary institutional protocol based on the ERAS concept, the “TotalCor protocol”. After the propensity score matching, 46 patients from the entire population were adjusted for 12 variables. Patients operated on the TotalCor protocol had reduced intensive care unit time (P < 0.025), postoperative stay (P ≤ 0.001) and length of hospital stay (P ≤ 0.001). In addition, there were no significant differences in the occurrence of complications and death between the two groups. Of the 10-central metrics of TotalCor protocol, 6 had > 70% adherences. In conclusion, the TotalCor protocol was safe and effective for a 3-day discharge after cardiac surgery. Postoperative atrial fibrillation and renal failure were predictors of postoperative stay > 5 days.

6 July 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OMOmar A. V. Mejia
Omar A. V. Mejia
MAManuel J. Antunes
Manuel J. Antunes
MGMaxim Goncharov
Maxim Goncharov
LDLuís R. P. Dallan
Luís R. P. Dallan
EVElinthon Veronese
Elinthon Veronese
FJFabio B. Jatene
Fabio B. Jatene
Mortality prediction after cardiac procedures is an essential tool in clinical decision making. Although rheumatic cardiac disease remains a major cause of heart surgery in the world no previous study validated risk scores in a sample exclusively with this condition. Develop a novel predictive model focused on mortality prediction among patients undergoing cardiac surgery secondary to rheumatic valve conditions. We conducted prospective consecutive all-comers patients with rheumatic heart disease (RHD) referred for surgical treatment of valve disease between May 2010 and July of 2015. Risk scores for hospital mortality were calculated using the 2000 Bernstein-Parsonnet, EuroSCORE II, InsCor, AmblerSCORE, GuaragnaSCORE, and the New York SCORE. In addition, we developed the rheumatic heart valve surgery score (RheSCORE). A total of 2,919 RHD patients underwent heart valve surgery. After evaluating 13 different models, the top performing areas under the curve were achieved using Random Forest (0.982) and Neural Network (0.952). Most influential predictors across all models included left atrium size, high creatinine values, a tricuspid procedure, reoperation and pulmonary hypertension. Areas under the curve for previously developed scores were all below the performance for the RheSCORE model: 2000 Bernstein-Parsonnet (0.876), EuroSCORE II (0.857), InsCor (0.835), Ambler (0.831), Guaragna (0.816) and the New York score (0.834). A web application is presented where researchers and providers can calculate predicted mortality based on the RheSCORE. The RheSCORE model outperformed pre-existing scores in a sample of patients with rheumatic cardiac disease.

10 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BOBianca Maria Maglia Orlandi
Bianca Maria Maglia Orlandi
OMOmar Asdrúbal Vilca Mejia
Omar Asdrúbal Vilca Mejia
GBGabrielle Barbosa Borgomoni
Gabrielle Barbosa Borgomoni
MGMaxim Goncharov
Maxim Goncharov
KRKenji Nakahara Rocha
Kenji Nakahara Rocha
RGREPLICCAR II Study Group
REPLICCAR II Study Group
The quality of data in electronic healthcare databases is a critical component when used for research and health practice. The aim of the present study was to assess the data quality in the Paulista Cardiovascular Surgery Registry II (REPLICCAR II) using two different audit methods, direct and indirect. The REPLICCAR II database contains data from 9 hospitals in São Paulo State with over 700 variables for 2229 surgical patients. The data collection was performed in REDCap platform using trained data managers to abstract information. We directly audited a random sample (n = 107) of the data collected after 6 months and indirectly audited the entire sample after 1 year of data collection. The indirect audit was performed using the data management tools in REDCap platform. We computed a modified Aggregate Data Quality Score (ADQ) previously reported by Salati et al. (2015). The agreement between data elements was good for categorical data (Cohen κ = 0.7, 95%CI = 0.59–0.83). For continuous data, the intraclass coefficient (ICC) for only 2 out of 15 continuous variables had an ICC < 0.9. In the indirect audit, 77% of the selected variables (n = 23) had a good ADQ score for completeness and accuracy. Data entry in the REPLICCAR II database proved to be satisfactory and showed competence and reliable data for research in cardiovascular surgery in Brazil.

1 February 2020 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
OMOmar A.V. Mejia
Omar A.V. Mejia
LLLuiz Augusto Ferreira Lisboa
Luiz Augusto Ferreira Lisboa
EAElisandra Trevisan Arita
Elisandra Trevisan Arita
CBCarlos Manuel de Almeida Brandão
Carlos Manuel de Almeida Brandão
RDRicardo Ribeiro Dias
Ricardo Ribeiro Dias
FJFabio Biscegli Jatene
Fabio Biscegli Jatene
The current challenge of cardiovascular surgery (CVS) is to improve the outcomes in increasingly severe patients. In this respect, continuous quality improvement (CQI) programs have had an impact on outcomes. To assess the evolution of the incidence and mortality due to CVS, as well as the current outcomes of the Hospital das Clínicas Heart Institute of the University of São Paulo Medical School (InCor-HCFMUSP). An outcome analysis of CVSs performed at the InCor, between January 1984 and June 2019. We observed the surgical volume and mortality rates in 5 time periods: 1st (1984-1989), 2nd (1990-1999), 3rd (2000-2007), 4th (2008-2015) and 5th (2016-2019). The CQI program was implemented between 2015 and 2016. The analysis included the total number of surgeries and the evolution of the most frequent procedures. A total of 105,599 CCVs were performed, with an annual mean of 2,964 procedures and mortality of 5,63%. When comparing the 4th and the 5th periods, the average global volume of surgeries was increased from 2,943 to 3,139 (p = 0.368), bypass graft (CABG), from 638 to 597 (p = 0.214), heart valve surgery, from 372 to 465 (p = 0.201), and congenital heart disease surgery, from 530 to 615 (p = 0.125). The average global mortality went from 7.8% to 5% (p < 0.0001); in CABG surgery, from 5.8% to 3.1% (p < 0.0001); in heart valve surgery, from 14% to 7.5% (p < 0.0001) and in congenital heart disease surgery, from 12.1% to 9.6% (p < 0.0001). In spite of a recent trend towards increased surgical volume, there was a significant decrease in operative mortality in the groups studied. After the implementation of the CQI program, the mortality rates were closer to international standards.

10 September 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OMOmar Asdrúbal Vilca Mejia
Omar Asdrúbal Vilca Mejia
GBGabrielle Barbosa Borgomoni
Gabrielle Barbosa Borgomoni
JZJorge Passamani Zubelli
Jorge Passamani Zubelli
LDLuís Roberto Palma Dallan
Luís Roberto Palma Dallan
PPPablo Maria Alberto Pomerantzeff
Pablo Maria Alberto Pomerantzeff
RGREPLICCAR Study Group
REPLICCAR Study Group
The objectives of this study were to describe a novel statewide registry for cardiac surgery in Brazil (REPLICCAR), to compare a regional risk model (SPScore) with EuroSCORE II and STS, and to understand where quality improvement and safety initiatives can be implemented. A total of 11 sites in the state of São Paulo, Brazil, formed an online registry platform to capture information on risk factors and outcomes after cardiac surgery procedures for all consecutive patients. EuroSCORE II and STS values were calculated for each patient. An SPScore model was designed and compared with EuroSCORE II and STS to predict 30-day outcomes: death, reoperation, readmission, and any morbidity. A total of 5222 patients were enrolled in this study between November 2013 and December 2017. The observed 30-day mortality rate was 7.6%. Most patients were older, overweight, and classified as New York Heart Association (NYHA) functional class III; 14.5% of the patient population had a positive diagnosis of rheumatic heart disease, 10.9% had insulin-dependent diabetes, and 19 individuals had a positive diagnosis of Chagas disease. When evaluating the prediction performance, we found that SPScore outperformed EuroSCORE II and STS in the prediction of mortality (0.90 vs. 0.76 and 0.77), reoperation (0.84 vs. 0.60 and 0.56), readmission (0.84 vs. 0.55 and 0.51), and any morbidity (0.80 vs. 0.65 and 0.64), respectively (p<0.001). The REPLICCAR registry might stimulate the creation of other cardiac surgery registries in developing countries, ultimately improving the regional quality of care provided to patients.

1 January 2013 in Arquivos Brasileiros de Cardiologia
Verified
Journal Article
Open access
OMOmar A. V. Mejía
Omar A. V. Mejía
LLLuiz A. F. Lisboa
Luiz A. F. Lisboa
LPLuiz B. Puig
Luiz B. Puig
LMLuiz Felipe P. Moreira
Luiz Felipe P. Moreira
LDLuis A. O. Dallan
Luis A. O. Dallan
NSNoedir A. G. Stolf
Noedir A. G. Stolf
Risk scores show difficulties to attain the same performance in different populations. To create a simple and accurate risk assessment model for patients submitted to surgery due to coronary and/or valvular disease at Instituto do Coração da Universidade de São Paulo (InCor-HCFMUSP). Between 2007 and 2009, 3,000 patients were submitted to surgical procedure due to coronary artery and/or valvular disease at InCor-HCFMUSP. From this record, data of 2/3 of the patients were used for model development (bootstrap technique), and 1/3 for internal validation of the model. The performance of the model (InsCor) was compared to the 2000 Bernstein-Parsonnet (2000BP) and EuroSCORE (ES) complexes. Only 10 variables were selected: age > 70 years, female sex; coronary revascularization + valve, myocardial infarction < 90 days; reoperation; surgical treatment of aortic valve; surgical treatment of tricuspid valve; creatinine < 2mg/dL; ejection fraction < 30%, and events. The Hosmer Lemeshow test for the InsCor was 0.184, indicating excellent calibration. The area under the ROC curve was 0.79 for the InsCor, 0.81 for the ES and 0.82 for 2000BP, confirming that the models are good and have similar discrimination. The InsCor and ES performed better than 2000BP at all stages of validation, but the new model, in addition to showing identification with the local risk factors, is simpler and more objective for mortality prediction in patients undergoing surgery due to coronary and/or valvular disease at InCor-HCFMUSP.